BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17385213)

  • 1. Efficient automated assessment of genetic abnormalities detected by fluorescence in situ hybridization on brush cytology in a Barrett esophagus surveillance population.
    Rygiel AM; van Baal JW; Milano F; Wang KK; ten Kate FJ; Fockens P; Rosmolen WD; Bergman JJ; Peppelenbosch MP; Krishnadath KK
    Cancer; 2007 May; 109(10):1980-8. PubMed ID: 17385213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence in situ hybridization to evaluate dysplasia in Barrett's esophagus: a pilot study.
    Cestari R; Villanacci V; Rossi E; Della Casa D; Missale G; Conio M; Grigolato P; Bassotti G
    Cancer Lett; 2007 Jun; 251(2):278-87. PubMed ID: 17321043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barrett's esophagus brush cytology specimens.
    Rygiel AM; Milano F; Ten Kate FJ; de Groot JG; Peppelenbosch MP; Bergman JJ; Krishnadath KK
    Genes Chromosomes Cancer; 2008 May; 47(5):396-404. PubMed ID: 18265409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal gains and genomic loss of p53 and p16 genes in Barrett's esophagus detected by fluorescence in situ hybridization of cytology specimens.
    Fahmy M; Skacel M; Gramlich TL; Brainard JA; Rice TW; Goldblum JR; Connor JT; Casey G; Legator MS; Tubbs RR; Falk GW
    Mod Pathol; 2004 May; 17(5):588-96. PubMed ID: 15017433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
    Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stepwise radical endoscopic resection of the complete Barrett's esophagus with early neoplasia successfully eradicates pre-existing genetic abnormalities.
    Peters FP; Krishnadath KK; Rygiel AM; Curvers WL; Rosmolen WD; Fockens P; Ten Kate FJ; van Baal JW; Bergman JJ
    Am J Gastroenterol; 2007 Sep; 102(9):1853-61. PubMed ID: 17509033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder.
    Hartmann A; Schlake G; Zaak D; Hungerhuber E; Hofstetter A; Hofstaedter F; Knuechel R
    Cancer Res; 2002 Feb; 62(3):809-18. PubMed ID: 11830537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oncogene amplification and genetic heterogeneity in the metaplasia-dysplasia-adenocarcinoma sequence of Barrett esophagus].
    Walch A; Bink K; Hutzler P; Zitzelsberger H; Braselmann H; Aubele M; Höfler H; Werner M
    Verh Dtsch Ges Pathol; 2001; 85():257-63. PubMed ID: 11894407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysomy and p16 deletion by fluorescence in situ hybridization in the diagnosis of indeterminate biliary strictures.
    Gonda TA; Glick MP; Sethi A; Poneros JM; Palmas W; Iqbal S; Gonzalez S; Nandula SV; Emond JC; Brown RS; Murty VV; Stevens PD
    Gastrointest Endosc; 2012 Jan; 75(1):74-9. PubMed ID: 22100297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
    Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
    Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
    Asali MG; Kaneti J; Manor E
    Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
    Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
    Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of locus-specific probes for interphase fluorescence in situ hybridisation--application in Barrett's esophagus.
    Doak SH; Saidely D; Jenkins GJ; Parry EM; Griffiths AP; Baxter JN; Parry JM
    Exp Mol Pathol; 2004 Aug; 77(1):26-33. PubMed ID: 15215047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between histologic findings and cytogenetic abnormalities in bladder carcinoma: a FISH study.
    Placer J; Espinet B; Salido M; Solé F; Gelabert-Mas A
    Urology; 2005 May; 65(5):913-8. PubMed ID: 15882723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities in chromosome 17 and p53 in lung carcinoma cells detected by fluorescence in situ hybridization.
    Kawai T; Hiroi S; Nakanishi K; Sakurai Y; Torikata C
    Pathol Int; 2004 Jun; 54(6):413-9. PubMed ID: 15144400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Numeric aberrations of HER-2 and chromosome 17 detected by fluorescence in situ hybridization in urine-exfoliated cells from patients with urothelial carcinoma.
    Inoue T; Sato K; Tsuchiya N; Matsuura S; Iinuma M; Habuchi T; Kato T
    Urology; 2004 Sep; 64(3):617-21. PubMed ID: 15351620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence in situ hybridization analysis of HER-2/neu, c-myc, and p53 in endometrial cancer.
    Williams JA; Wang ZR; Parrish RS; Hazlett LJ; Smith ST; Young SR
    Exp Mol Pathol; 1999 Dec; 67(3):135-43. PubMed ID: 10600396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular cytogenetic study of bladder transitional cell carcinoma by FISH].
    Shou J; Wang M; Ma J
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):36-8. PubMed ID: 11776593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer.
    Moonen PM; Merkx GF; Peelen P; Karthaus HF; Smeets DF; Witjes JA
    Eur Urol; 2007 May; 51(5):1275-80; discussion 1280. PubMed ID: 17084511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A public-domain image processing tool for automated quantification of fluorescence in situ hybridisation signals.
    Konsti J; Lundin J; Jumppanen M; Lundin M; Viitanen A; Isola J
    J Clin Pathol; 2008 Mar; 61(3):278-82. PubMed ID: 17693574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.